Fuji Pharma Co., Ltd. (TYO:4554)
Japan · Delayed Price · Currency is JPY 1,857.00
-21.00 (-1.12%)
Nov 13, 2026, 3:30 PM JST
Fuji Pharma Market Cap
Fuji Pharma has a market cap or net worth of 48.5 billion as of November 13, 2026. It is the 17,879th most valuable company in the world and the 1,378th biggest in Japan. Its market cap has increased by 20.06% in one year.
Market Cap
48.50B
Enterprise Value
67.39B
Revenue
62.39B
Global Rank
Country Rank
#1,378 Japan
PE Ratio
16.70
ChartMarket Cap Chart
Since December 21, 2005, Fuji Pharma's market cap has increased from 17.38B to 48.50B, an increase of 179.01%. That is a compound annual growth rate of 5.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 48.50B | 5.05% |
| Dec 30, 2025 | 46.17B | 18.77% |
| Dec 30, 2024 | 38.88B | -8.01% |
| Dec 29, 2023 | 42.26B | 70.05% |
| Dec 30, 2022 | 24.85B | -0.36% |
| Dec 30, 2021 | 24.94B | -35.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kissei Pharmaceutical | 162.15B |
| Kaken Pharmaceutical | 144.85B |
| Mochida Pharmaceutical | 117.84B |
| Zeria Pharmaceutical | 92.04B |
| KYORIN Pharmaceutical | 62.04B |
| ASKA Pharmaceutical Holdings | 61.45B |
| Daito Pharmaceutical | 37.22B |
| Koa Shoji Holdings | 35.21B |